LLL. I. Lepeshkina

L. I. Lepeshkina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


L. I. Lepeshkina has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Routing of patients with disorders of carbohydrate metabolism during pregravid preparation and pregnancy (literature review)

    by L. I. Lepeshkina, S. Yu. Vorotnikova, N. G. Mokrysheva, Л. И. Лепешкина, С. Ю. Воротникова, Н. Г. Мокрышева

    Introduction. The increasing incidence of gestational diabetes mellitus and other first-time diagnosed carbohydrate metabolism disorders during pregnancy, along with the associated obstetric and perinatal risks, represents a significant medical and social challenge. The current stage of healthcare development in the Russian Federation is characterized by active modernization of clinical protocols and the regulatory framework governing medical care in the field of endocrinology. However, documents specifying the organization of medical care for pregnant women with gestational diabetes mellitus have not been developed. The purpose of the study : to study and systematize the literature data and regulatory documents reflecting the organization of medical care for pregnant women with impaired carbohydrate metabolism, including to assess the current routing situation of patients with gestational diabetes mellitus. Materials and methods . An analysis was conducted of 106 international (PubMed, Scopus, Medline) and Russian publications (2012–2025), as well as 9 key regulatory documents of the Russian Federation governing care for patients with carbohydrate metabolism disorders. Data systematization was performed using Microsoft Excel. Results. The article examines current regulatory documents reflecting the organization of medical care for pregnant women with carbohydrate metabolism disorders. A detailed analysis of medical care procedures, several orders of the Ministry of Health of Russia, and federal laws was carried out to identify gaps and contradictions in the legal regulation of this group of diseases. In particular, issues of routing patients with established gestational diabetes mellitus are discussed in terms of diagnosis, treatment, delivery, and postpartum management. Detailed data are presented indicating limitations in the existing regulatory framework concerning pregravid preparation of patients with carbohydrate metabolism disorders. The problem caused by untimely consultations with endocrinologists and other specialists is separately characterized. Conclusion. Improving the medical and economic efficiency of managing pregnant women with carbohydrate metabolism disorders and minimizing the risks caused by hyperglycemia during pregnancy, including long-term complications, can only be achieved through the development of regulatory documents on the organization of medical care for this population group and their implementation nationwide.

  • Open Access

    «Gestational Hyperandrogenism»: Clarifying Terminology and Practical Management

    by L. I. Lepeshkina, S. Y. Vorotnikova, G. A. Mel’nIchenko

    This review examines the terminological ambiguity surrounding the concept of «gestational hyperandrogenism» in domestic literature and clinical practice. An increase in androgen levels during pregnancy, driven by hormonal adaptation, involvement of the fetoplacental complex, and altered synthesis of sex hormone-binding globulins in the liver, represents a physiological norm. Consequently, patient management in most cases is limited to active monitoring and does not require medical intervention. A key emphasis is placed on distinguishing between pregestational hyperandrogenism and true gestational hyperandrogenism — a rare pathological condition that first manifests during pregnancy due to causes such as luteoma, theca-lutein cysts, or placental aromatase deficiency, all of which typically resolve spontaneously after delivery. The review outlines a systematic approach to the differential diagnosis of these conditions, which is crucial for determining further management strategy and preventing inappropriate treatment. Incorrect interpretation of laboratory findings and overdiagnosis often lead to the erroneous prescription of glucocorticoids to pregnant women, posing potential risks. The article delineates patient management strategies based on identifying the source of hyperandrogenism and assessing the risk of fetal virilization, with an emphasis on dynamic monitoring. Particular attention is paid to the need for topical diagnosis using imaging techniques, as well as the dynamic assessment of androgen status postpartum. Treatment options for true gestational hyperandrogenism are limited, whereas glucocorticoid therapy is justified only in cases of pregestational hyperandrogenism due to congenital adrenal hyperplasia.

  • Open Access

    Overcoming therapy resistance in prolactinomas: from perspectives to real clinical practice

    by A. S. Shutova, E. A. Pigarova, L. I. Lepeshkina, V. A. Ioutsi, M. Yu. Drokov, S. Y. Vorotnikova, L. I. Astafyeva, L. K. Dzeranova

    Преодоление резистентности пролактином к медикаментозной терапии: от перспектив к реальной клинической практике


  • Open Access

    Acromegaly in the differential diagnosis of hearing loss

    by L. K. Dzeranova, L. I. Lepeshkina, A. S. Shutova, M. A. Perepelova, E. A. Pigarova, V. N. Azizyan, P. V. Akopyan, Е. G. Przhialkovskaya, G. A. Melnichenko, N. G. Mokrysheva

    Acromegaly is a multifactorial neuroendocrine disease caused by hyperproduction of growth hormone (GH). In more than 95% of cases the reason of acromegaly the GH-secreting pituitary adenoma. In patients with this neuroendocrine disease, a slowly developing complex of symptom can manifest with concomitant pathological conditions, including auditory function disordersDiagnostic difficulties of acromegaly at the ambulatory stage determine the importance of doctor`s awareness in different medical specialties.Here we demonstrate a clinical case of the improvement of the auditory function due to combined surgical and medical treatment of a patient with the pituitary macroadenoma, acromegaly and hearing loss.Anamnesis features: a patient with an active stage of acromegaly and a pituitary macroadenoma measuring 57x35x32 mm with ante-, supra-, infra-, parasellar spread, (Knosp III(D), Knosp IV(S) noted a violation of auditory function. She was consulted by an otolaryngologist, sensorineural hearing loss on the right of the 3rd degree was diagnosed, on the left of the 1st degree. The patient underwent surgical treatment of pituitary adenoma, noted a significant improvement in auditory function in the early postoperative period. Six months later, repeated audiometry was performed, marked regression of hearing damage was noted.The case described by us indicates the reversibility of a rare complication of acromegaly — hearing loss and the importance of an interdisciplinary approach in the management of patients with this pathology.